EUROLAB
usp-1241-capsules-and-shell-impurity-interaction
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

USP <1241>: Capsules and Shell Impurity Interaction Laboratory Testing Service Provided by Eurolab

USP <1241> is a standard developed by the United States Pharmacopeia (USP) that outlines the requirements for testing capsules and shell impurities. The standard is designed to ensure that capsules do not release harmful substances, such as heavy metals or other contaminants, into the body.

The legal and regulatory framework surrounding this testing service is governed by various international and national standards. Some of these standards include:

  • ISO 17025: General requirements for the competence of testing and calibration laboratories

  • ASTM E3007-16: Standard Guide for Evaluating the Impurities in Pharmaceutical Capsules

  • EN ISO 11133:2014: Microbiology - Preparation, use, performance, and maintenance of cultural media

  • TSE 1331:2016: Pharmaceutical capsules and shells - Determination of extractable materials

    • Standard development organizations play a crucial role in creating and maintaining standards like USP <1241>. These organizations include:

  • United States Pharmacopeia (USP)

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

    • Standards evolve and get updated as new research and technologies emerge. This ensures that testing services like Eurolabs USP <1241> remain relevant and effective in detecting impurities.

    Here are some specific standard numbers and their scope:

    Standard Number Title Scope

    --- --- ---

    ISO 17025:2018 General requirements for the competence of testing and calibration laboratories Provides general requirements for testing and calibration laboratories to ensure competence.

    ASTM E3007-16 Standard Guide for Evaluating the Impurities in Pharmaceutical Capsules Outlines a guide for evaluating impurities in pharmaceutical capsules.

    Standard compliance is essential for various industries, including:

  • Pharmaceuticals

  • Food and Beverage

  • Cosmetics

  • Chemicals

    • Non-compliance can result in product recalls, regulatory actions, and damage to reputation.

    The USP <1241> test is necessary due to the following reasons:

  • Business reasons: Conducting this test helps ensure compliance with regulations, reducing the risk of product recalls and regulatory actions.

  • Technical reasons: The test detects potential impurities in capsules, which can be detrimental to human health.

    • Consequences of not performing this test include:

  • Product contamination

  • Regulatory non-compliance

  • Damage to reputation

  • Financial losses

    • The industries that require USP <1241> testing include:

  • Pharmaceuticals

  • Food and Beverage

  • Cosmetics

  • Chemicals

    • Risk factors associated with capsule impurities include:

  • Contamination with heavy metals or other hazardous substances

  • Ingestion of toxic chemicals

  • Allergic reactions to shell materials

    • Quality assurance and quality control measures are essential during this testing service.

    Conducting the USP <1241> test involves the following steps:

    1. Sample preparation: Capsules are extracted with a solvent, such as methanol or acetonitrile.

    2. Testing equipment: High-performance liquid chromatography (HPLC) or gas chromatography (GC) is used to separate and detect impurities.

    3. Testing environment: The testing laboratory must maintain controlled temperature (20C 5C), humidity (50 10), and pressure conditions.

    Here are the detailed measurement and analysis methods:

  • HPLC: Detection of impurities using UV or mass spectrometry

  • GC: Separation and detection of volatile organic compounds

    • Calibration and validation procedures ensure accuracy and precision during testing. Quality control measures include:

  • Sample homogeneity

  • Calibration curve verification

  • Method validation

    • Data collection and recording are performed in accordance with standard laboratory practices.

    Results from the USP <1241> test are documented and reported as follows:

  • Report format: The report includes a summary of testing parameters, results, and conclusions.

  • Interpretation of test results: Impurities detected above a specified limit are considered non-compliant.

    • Certification and accreditation details include:

  • Eurolabs ISO 17025:2018 certification

  • Accreditation to relevant national standards

    • Benefits and advantages of conducting USP <1241> testing include:

  • Risk assessment: Detecting potential impurities ensures product safety.

  • Quality assurance: Compliance with regulations is ensured, reducing the risk of regulatory actions.

  • Competitive advantage: Companies that conduct this test demonstrate commitment to quality and safety.

    • Eurolabs USP <1241> testing service offers:

  • Expertise: Experienced laboratory technicians and scientists perform the tests.

  • Accreditation: Eurolab is certified to ISO 17025:2018, ensuring competence in testing services.

  • State-of-the-art equipment: Modern HPLC and GC instruments provide accurate results.

    • We hope this comprehensive guide provides valuable insights into USP <1241> testing. Contact us today for more information on our laboratory testing services!

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers